Corner Office Conversation: Cognizant CEO Rav...

A quiet revolution is underway in Indian oncology. Chinese-origin cancer drugs, brought to India through a growing number of pharma partnerships, are dramatically cutting the cost of immunotherapy — making treatment accessible to patients who previously had no options. Doctors ar ...  Show more

When an AI system can autonomously find and exploit vulnerabilities at scale — who controls the risk? In this episode of The Morning Brief, host Anirban Chowdhury sits down with Gary Marcus, AI expert, scientist and author to examine Anthropic's Mythos — a frontier AI system buil ...  Show more

About this episode: Host Benjamin Ensor, Director of Research and Strategy, is joined by a fantastic panel of guests as we dive into some of the biggest stories from the worlds of fintech, banking, and wider financial services this week. Stories covered on the podcast this week i ...  Show more

Daron Acemoğlu is an economics professor at the Massachusetts Institute of Technology and the author of Power and Progress: Our Thousand-Year Struggle Over Technology and Prosperity. Today on the show, he and Soumaya discuss artificial intelligence and productivity gr ...

About this episode: AI is everywhere-your newsfeed, your boardroom, your LinkedIn inbox. But when it comes to real, customer-facing use cases in finance… there’s not much to see. Why isn’t AI transforming the customer experience yet? What’s working behind the scenes, and what’s j ...  Show more

How will US tech firms react to DeepSeek? The Chinese artificial intelligence start-up says it can match Google and ChatGPT at a fraction of the cost. Donald Trump says it's a wake-up call for developers. So, who will dominate in this bitter digital rivalry? In this Episode:   Ra ...  Show more